GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we handle type 2 diabetes . These injectable drugs help stimulating the body’s own GLP-1 process, https://bookmarksea.com/story21653188/glp-1-a-revolutionary-breakthrough-in-glucose-management